All news

Merck adds Paul Diaz to board of directors

Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash

Merck & Co. appointed Paul J. Diaz, managing partner at Cressey & Company, to its board of directors effective November 1, 2026. Diaz previously served as CEO of Myriad Genetics and Kindred Healthcare, bringing healthcare leadership experience that is expected to strengthen Merck's governance and strategic insight.

Read original source

MRK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.